ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Rani Therapeutics (RANI)
Rani Therapeutics stock price today, ATLAS forecast and fair value
Healthcare · Biotechnology · NASDAQ
$0.62▲ +1.85%
Prices as of Oct 26, 2026 · USD
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Rani Therapeutics in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Rani Therapeutics
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Rani Therapeutics a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $0.54 and $0.69; in 9 out of 10, between $0.43 and $0.86. Estimated annual volatility is 67%.
Price, last 12 months (weekly close)
Key numbers
- 52-week high
- $2.63
- 52-week low
- $0.57
- Revenue (12 months)
- $4.9M
- Revenue growth (YoY)
- +58.9%
- Gross margin
- 0.0%
- Return on equity
- -172.1%
- Free cash flow (12 months)
- $-8.9M
- Beta
- 0.71
What this means
ATLAS does not publish a fair value for RANI right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks RANI has traded between $0.57 and $2.63. Today it is 76.5% below that high and 9% above its low.
Its beta is 0.71: it tends to move less than the market.
About the company
Rani Therapeutics Holdings, Inc. Class A Common Stock represents equity in Rani Therapeutics, a clinical-stage biotherapeutics company focused on oral delivery technologies for biologics and other drugs.
Want to see everything about Rani Therapeutics?
Get started →Plans from €3.99 a month.
Frequently asked questions
What does Rani Therapeutics do?
Rani Therapeutics Holdings, Inc. Class A Common Stock represents equity in Rani Therapeutics, a clinical-stage biotherapeutics company focused on oral delivery technologies for biologics and other drugs.
What is the chance RANI goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, RANI ends the month between $0.54 and $0.69.
How volatile is RANI?
ATLAS estimates annual volatility at 67%. In a typical month, half of the outcomes end between $0.54 and $0.69.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer